TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06206161

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Indicated Prevention, Clinical Staff
Description: Standard brief intervention eligibility criteria involving indicated prevention (i.e., brief interventions delivered to high-risk drinkers only). BIs delivered by standard SBIRT workforce involving school nursing or clinical staff.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Indicated Prevention, Clinical Staff
Description: Standard brief intervention eligibility criteria involving indicated prevention (i.e., brief interventions delivered to high-risk drinkers only). BIs delivered by standard SBIRT workforce involving school nursing or clinical staff.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Indicated Prevention, Clinical Staff
Description: Standard brief intervention eligibility criteria involving indicated prevention (i.e., brief interventions delivered to high-risk drinkers only). BIs delivered by standard SBIRT workforce involving school nursing or clinical staff.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Indicated Prevention, Clinical Staff
Description: Standard brief intervention eligibility criteria involving indicated prevention (i.e., brief interventions delivered to high-risk drinkers only). BIs delivered by standard SBIRT workforce involving school nursing or clinical staff.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Selective Prevention
Description: Expanded brief intervention eligibility criteria involving selective prevention in addition to indicated prevention (i.e., brief interventions delivered to current drinkers with and without risky alcohol use).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Selective Prevention
Description: Expanded brief intervention eligibility criteria involving selective prevention in addition to indicated prevention (i.e., brief interventions delivered to current drinkers with and without risky alcohol use).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expanded Paraprofessional Workforce
Description: Brief interventions delivered by expanded SBIRT workforce involving school nursing or clinical staff and trained paraprofessionals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expanded Paraprofessional Workforce
Description: Brief interventions delivered by expanded SBIRT workforce involving school nursing or clinical staff and trained paraprofessionals.
Study: NCT05364463

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Methods for cannulating the radial artery in a cardiac catheterization
Description: The puncture will be performed in each participant according to the method has been assigned randomly: ultrasound and hyperemia, ultrasound only, hyperemia only, palpation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Methods for cannulating the radial artery in a cardiac catheterization
Description: The puncture will be performed in each participant according to the method has been assigned randomly: ultrasound and hyperemia, ultrasound only, hyperemia only, palpation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Methods for cannulating the radial artery in a cardiac catheterization
Description: The puncture will be performed in each participant according to the method has been assigned randomly: ultrasound and hyperemia, ultrasound only, hyperemia only, palpation.
Study: NCT05375591

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: First nodule detection CT scans as per eligibility criteria will be used as input into in-house software to extract multiple radiomic features and used to develop a machine learning based classifier to differentiate nodule aetiology. Scans will also be used as input in to a deep learning/convolutional neural network models to perform automated imaging classification.

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: First nodule detection CT scans as per eligibility criteria will be used as input into in-house software to extract multiple radiomic features and used to develop a machine learning based classifier to differentiate nodule aetiology. Scans will also be used as input in to a deep learning/convolutional neural network models to perform automated imaging classification.

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: First nodule detection CT scans as per eligibility criteria will be used as input into in-house software to extract multiple radiomic features and used to develop a machine learning based classifier to differentiate nodule aetiology. Scans will also be used as input in to a deep learning/convolutional neural network models to perform automated imaging classification.
Study: NCT05413161

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADL-018
Description: 150 mg/mL, Solution for injection in PFS

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: US-licensed XOLAIR
Description: 150 mg/mL, Solution for injection in PFS

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: EU-Approved XOLAIR
Description: 150 mg/mL, Solution for injection in PFS
Study: NCT05947318

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial alternating current stimulation 70 Hz
Description: Transcranial alternating current stimulation in the head above the motor cortex area of one side of the brain, according to the hemiparesis side.~Electrodes with 3.14 cm2 of stimulation area will be used, therefore, the initial current intensity will be 0.21 mA, with a current density of 0.07 mA / cm2. The current intensity will be adjusted to the tactile sensory threshold and phosphenes of each patient, with in order to reduce such sensory effects, but considering that the decrease in current will not be greater than 10% of the initial intensity, in order to obtain a comparable configuration between subjects.~The frequency stimulation will be 70 Hz

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Training
Description: Training of the upper limb with specific kinematic and kinetic tasks plus functional training

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training
Description: Training of the upper limb with specific kinematic and kinetic tasks plus functional training

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Training
Description: Training of the upper limb with specific kinematic and kinetic tasks plus functional training

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial alternating current stimulation 7 Hz
Description: Transcranial alternating current stimulation in the head above the motor cortex area of one side of the brain, according to the hemiparesis side.~Electrodes with 3.14 cm2 of stimulation area will be used, therefore, the initial current intensity will be 0.21 mA, with a current density of 0.07 mA / cm2. The current intensity will be adjusted to the tactile sensory threshold and phosphenes of each patient, with in order to reduce such sensory effects, but considering that the decrease in current will not be greater than 10% of the initial intensity, in order to obtain a comparable configuration between subjects.~The frequency stimulation will be 7 Hz

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial alternating current stimulation Sham
Description: Transcranial alternating current stimulation in the head above the motor cortex area of one side of the brain, according to the hemiparesis side.~Electrodes with 3.14 cm2 of stimulation area will be used, therefore, the initial current intensity will be 0.21 mA, with a current density of 0.07 mA / cm2. The current intensity will be adjusted to the tactile sensory threshold and phosphenes of each patient, with in order to reduce such sensory effects, but considering that the decrease in current will not be greater than 10% of the initial intensity, in order to obtain a comparable configuration between subjects.~The stimulation will be turn on for 30 seconds (at 70 Hz)
Study: NCT05585008

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: two different denture manufacturing technique (heat cure pack and press technique(heat cure acrylic,Acrostone,Egypt)/3d printed dneture(HARZ lab,Russia))
Description: retention for the two groups will be measured at 0,1 and 3months, patient satisfaction will be recorded, and accuracy of the denture base will be measured on the software.
Study: NCT06202963

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide
Description: 1. group will receive ultrasound-guided hydrodilatation~2. group will receive ultarsound-guided coracohumeral hydrorelease in addition to the ultrasound-guided hydrodilaltation of shoulder

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide
Description: 1. group will receive ultrasound-guided hydrodilatation~2. group will receive ultarsound-guided coracohumeral hydrorelease in addition to the ultrasound-guided hydrodilaltation of shoulder
Study: NCT05366634

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MDK-703 or Placebo
Description: Injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MDK-703 or Placebo
Description: Injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MDK-703 or Placebo
Description: Injection
Study: NCT06042465

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture and Tui-na manipulations
Description: i. Patients in supine position with knee elevated 20-30 degrees bending using a pillow below.~ii. Acupuncture needle using 0.25 mm diameter and 1.5-inch length. iii. Choose 'A shi point' to inject the acupuncture needles. iv. Inject 4 acupuncture needles respectively at the upper, lower, lateral and medial edge of the patella, along the medial and lateral edge at the posterior surface of patella.~v. Connect the needles with electro-therapy, selecting high frequency and strength that the patients have sensation and acceptable. Time duration is 30 minutes each time. Infra-radiation is provided and warm above the treatment region.~vi. Tui-na manipulations using the method of 'Tui-na'. Time duration is 2-5 minutes. Patella is pushed up and elevated during treatment.~vii. No external herbal medicine for TCM group , other medication such as painkiller is required to record
Study: NCT05458206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mulligan snag mobilization and diaphragmatic release
Description: The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.~mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this glide as the patient actively moves in any range of physiological movement

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mulligan snag mobilization and diaphragmatic release
Description: The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.~mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this glide as the patient actively moves in any range of physiological movement
Study: NCT06114264

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal + Resistance Programs
Description: Exercise: will focus on working the all body by performing functional tasks. Behaviour change: An 'idle alert' of the wrist-worn activity prompter will be set to vibrate after 45 min without movement. Participants will be encouraged to take a 1-2 min activity break.~Education: The basic contents will explain to the patient the main mechanism of chronic pain (pain as a protective system, consequences, etc).~The Mindfulness Based Stress Reduction (MBSR) program will strictly follow the protocol developed by Jon Kabat Zinn. Each session will include three activities: the presentation of a topic, moments of dialogue and exploration in group and a Mindfulness practice.~Resistance functional exercises will replicate functional movements, such as standing from a bed, carrying bags, picking up groceries from the ground, etc.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: No experimental intervention. The group will receive the same multimodal intervention as the experimental group when the experimental period is over.
Study: NCT05361681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electromagnetic Field Exposure
Description: All participants were exposed to the electromagnetic field of 4-5 different high power charging systems, charging 4-5 different, commercially available full electric cars
Study: NCT05433220

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice Advisory using Electronic Health Record
Description: Providers caring for patients randomized to the intervention arm will have a best practice alert appear for each of their eligible patients upon opening of the order entry screen in the patient's medical record. This alert informs the provider to the presence of HFrEF, notes the patient's current LVEF and current evidence-based medications, and gives access to an order set with recommended evidence- based, guideline-recommended, and FDA- approved therapies for patients with HFrEF. Providers will also have access to a link to best available guideline recommended information regarding treatment of heart failure to allow further education if desired by the provider. The alerts will also clearly state the expected monitoring and follow-up required for prescriptions of these medications.
Study: NCT06042465

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: i. Total 12 sessions of physiotherapy for 8 weeks training; ii. Treatment: Closed kinetic chain exercises program will be used when appropriate, which include:~1. Mini walk squat exercise~2. Forward step up~3. Lateral step up~4. Terminal knee extension~5. Knee taping~6. Unstable base training~7. Pain control~8. Manual Therapy Each session will approximately cost each patient 1 hours' time. There is no Chinese medicine is allowed for PT group , other medication such as painkiller is required to record.
Study: NCT04712968

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular exposure to morning daylight
Description: Participants are asked to stay outside in morning daylight for minimum 30 minutes each day before 1 pm for 6 weeks. A specific plan for individual outdoor possibilities for daylight exposure is made (e.g. a walk, a stay in a park or in their garden, a bike trip). Furthermore a detailed instruction to the personal light tracker LYS Button and the matching LYS Insight app is provided. The LYS Insight app gives the user access to real-time insight of light stimulus. Further, the participants receive psycho-education on the connection between exposure to morning daylight and antidepressant effect. All participants in this group receive the intervention as add-on to usual treatment, which may comprise prescribed antidepressants, psychotherapy, including psycho-education and psychiatric care.
Study: NCT06297356

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stress ball
Description: Stress balls are soft sponges with a diameter of 2-4 cm. The lightest starting level was preferred for the patients. Patients were allowed to take the stress ball in any hand they wanted. They were asked to squeeze and loosen the ball in their palm at 2-3 second intervals.
Study: NCT05371964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imetelstat
Description: Imetelstat sodium will be administered as intravenous (IV) every 28 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Ruxolitinib will be administered, orally (PO), twice daily (BID) as the standard of care per local prescribing guidelines.
Study: NCT06650332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cadonilimab
Description: Cohort 1:10 mg/kg, iv, Q3W, D1; Cohort 2/3:6 mg/kg, iv, Q2W, D1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cadonilimab
Description: Cohort 1:10 mg/kg, iv, Q3W, D1; Cohort 2/3:6 mg/kg, iv, Q2W, D1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cadonilimab
Description: Cohort 1:10 mg/kg, iv, Q3W, D1; Cohort 2/3:6 mg/kg, iv, Q2W, D1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: loading dose 8 mg/kg, iv, Q3W, D1; maintenance dose 6 mg/kg, iv, Q3W, D1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: Oxaliplatin: 130 mg/m\\(\^2\\), IV, D1; Capecitabine: 1000 mg/m\\(\^2\\), oral (PO), twice daily, D1-14.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: 1.5、2.0、2.5mg/kg，IV，D1，Q2W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: 1.5、2.0、2.5mg/kg，IV，D1，Q2W
Study: NCT05458206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mulligan snag mobilization and diaphragmatic release
Description: The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.~mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this glide as the patient actively moves in any range of physiological movement

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mulligan snag mobilization and diaphragmatic release
Description: The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.~mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this glide as the patient actively moves in any range of physiological movement
Study: NCT06650332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6
Description: Oxaliplatin 85 mg/m\\(\^2\\), IV, d1; Leucovorin (folinic acid) 400 mg/m\\(\^2\\), IV, d1; 5-FU 400 mg/m\\(\^2\\), IV, d1, followed by 2400 mg/m\\(\^2\\), continuous intravenous infusion over 46 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6
Description: Oxaliplatin 85 mg/m\\(\^2\\), IV, d1; Leucovorin (folinic acid) 400 mg/m\\(\^2\\), IV, d1; 5-FU 400 mg/m\\(\^2\\), IV, d1, followed by 2400 mg/m\\(\^2\\), continuous intravenous infusion over 46 hours.
Study: NCT05392699

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human single chain IL-12 mRNA-single dose
Description: human single chain IL-12 mRNA administered as specified in the treatment arm with injection once only

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human single chain IL-12 mRNA-multiple dose
Description: human single chain IL-12 mRNA administered as specified in the treatment arm with injection once per week for 3 weeks
Study: NCT05558735

Intervention type: OTHER
Intervention: urine collection
Description: urine collection as part of the care and usual follow-up in the context of suspected prostate cancer

Intervention type: OTHER
Intervention: urine collection
Description: urine collection as part of the care and usual follow-up in the context of suspected prostate cancer

Intervention type: OTHER
Intervention: canine detection
Description: urine sample will be placed in a detection cone to be sniffed by 6 trained dogs

Intervention type: OTHER
Intervention: canine detection
Description: urine sample will be placed in a detection cone to be sniffed by 6 trained dogs
Study: NCT05288335

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Circular cylindrical mirror modulated frame glasses (compact)
Description: Circular cylindrical mirror modulated frame glasses (compact)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Circular cylindrical mirror modulated frame glasses (strong defocus)
Description: Circular cylindrical mirror modulated frame glasses (strong defocus)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: single vision frame glasses
Description: single vision frame glasses
Study: NCT06038370

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-induced cognitive trance
Description: The cognitive trance-based intervention will consist of a two-day workshop in groups of approximately 10 participants, where they will learn how to induce the cognitive trance, with the use of different sound-loops that can induce trance in untrained people in a safe way. After two weeks of home practice, participants will redo a two-day consolidation training. At-home practice is encouraged between sessions.
Study: NCT04890691

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Feel Bright Light
Description: During the first waking hour, the participants will be required to wear the light visor (either therapeutic or placebo light) for 30 minutes/day for 4 weeks.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Feel Bright Light
Description: During the first waking hour, the participants will be required to wear the light visor (either therapeutic or placebo light) for 30 minutes/day for 4 weeks.
Study: NCT04755491

Intervention type: DEVICE
Intervention: Continuous veno-venous hemofiltration
Description: Treatment of KDIGO stage 3 AKI by CVVH, in which renal replacement therapy is applied using a convection technique (ultrafiltration). Indication, choice of CRRT modality, and CRRT settings are made by the clinician in charge, following international recommendations. The measurement of chloride transfer over 24h is performed during CVVH treatment.

Intervention type: DEVICE
Intervention: Continuous veno-venous hemodialysis
Description: Treatment of KDIGO stage 3 AKI by CVVD, in which renal replacement therapy is applied using a diffusion technique (dialysis). Indication, choice of CRRT modality, and CRRT settings are made by the clinician in charge, following international recommendations. The measurement of chloride transfer over 24h is performed during CVVD treatment.